Chlamydia is an obligate intracellular bacterium that differentiates between two distinct 25 functional and morphological forms during its developmental cycle: elementary bodies (EBs) and 26 reticulate bodies (RBs). EBs are non-dividing, small electron dense forms that infect host cells. RBs 27 are larger, non-infectious replicative forms that develop within a membrane-bound vesicle, termed 28 an inclusion. Given the unique properties of each developmental form of this bacterium, we 29 hypothesized that the Clp protease system plays an integral role in proteomic turnover by degrading 30 specific proteins from one developmental form or the other. Chlamydia has five uncharacterized clp 31 genes: clpX, clpC, two clpP paralogs, and clpB. In other bacteria, ClpC and ClpX are chaperones that 32 unfold and feed proteins into the ClpP protease to be degraded, and ClpB is a deaggregase. Here, we 33 focused on characterizing the ClpP paralogs. Transcriptional analyses and immunoblotting 34 determined these genes are expressed mid-cycle. Bioinformatic analyses of these proteins identified 35 key residues important for activity. Over-expression of inactive clpP mutants in Chlamydia 36 suggested independent function of each ClpP paralog. To further probe these differences, we 37 determined interactions between the ClpP proteins using bacterial two-hybrid assays and Native gel 38 analysis of recombinant proteins. Homotypic interactions of the ClpP proteins, but not heterotypic 39 interactions between the ClpP paralogs, were detected. Interestingly, ClpP2, but not ClpP1, protease 40 activity was detected in vitro. This activity was stimulated by antibiotics known to activate ClpP, 41 which blocked chlamydial growth. Our data suggest the chlamydial ClpP paralogs likely serve 42 distinct and critical roles in this important pathogen. 43 Words: 250/250 44 45 3 Importance 46
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(Lm) were shown to form both hetero-and homotypic complexes (28) (29), yet the authors 106 demonstrated that Lm ClpP2 likely can function independently of Lm ClpP1. These studies, taken 107 together with the reductive evolution of the chlamydial genome, led us to hypothesize that the 108 chlamydial ClpPs may serve distinct and critical functions in the physiology of the organism. 109
To begin investigation of the role of the Clp protease system in chlamydial biology, we 110 initiated a series of studies to characterize the ClpP paralogs. All clp genes are transcribed as specific genes, and the translated product of clpP2 was detected during the developmental cycle. 112
Bioinformatic and structural modeling analyses indicate that these proteins retain key residues 113 important for function as well as structure. Interestingly, over-expression of a mutant ClpP1 was 114 detrimental to chlamydial development whereas a mutant ClpP2 had no observable effect. To 115 explore the basis of this observation, we performed a series of in vitro and in vivo assays indicating 116 homo-oligomerization of each paralog. However, we did not detect hetero-oligomerization between 117 these paralogs. We also characterized the in vitro protease activity of each ClpP paralog and 118 observed that activity was only detected for ClpP2. Antibiotics known to activate ClpP proteases 119 stimulated the protease activity of ClpP2 only and blocked chlamydial growth. Combined, our data 120 suggest ClpP1 activity may be tightly regulated. We conclude that each chlamydial ClpP protease 121 serves a unique and independent role, either in differentiation or more typical physiological 122 processes. 123 124
Results 125
The clp genes are expressed as RB specific genes. We hypothesize, based on the arrangement of 126 the genes in the chromosome, that ClpC interacts with ClpP1 and that ClpX interacts with ClpP2. 127
This does not preclude each individual component from acting independently and is not mutually 128 exclusive to our hypothesis. We base our prediction of ClpP2X interaction due to the juxtaposition of 129 Nucleic acid samples were collected for analysis at various time points of infection using wild-type 142 C. trachomatis serovar L2. Our data indicate that the clp genes analyzed are transcribed in a pattern 143 consistent with mid-cycle, RB specific function since the transcript levels peak after primary 144 differentiation has occurred and a population of RBs has been established (i.e. 16 hpi; Fig. 1B ). This 145 pattern is distinct to that of canonical early or late cycle genes such as euo or omcB (31) (32) (33) . 146
The clpX transcript levels closely mirrored those of clpP2 albeit with slightly lower transcript 147 abundance, consistent with its genomic context 3' to clpP2. 148
We next sought to detect endogenous protein of the ClpP paralogs. Given the high level of 149 homology between the Pseudomonas aeruginosa (Pa) ClpP1 and C. trachomatis (Ctr) ClpP2 (see 150 Fig. 2 ), we speculated a polyclonal antibody developed against Pa_ClpP1 (kind gift of Dr. T. Baker, 151 MIT) would detect Ctr ClpP2 by Western blot (see Suppl. Fig. S1 ). As seen, Ctr ClpP2 was detected 152 from infected cell lysates starting at 16h post-infection using the polyclonal anti-Pa_ClpP1 antibody 153 8 (Fig. 1C) . The polyclonal antibody developed against Pa_ClpP2 did not react with chlamydial 154 lysates or recombinant Ctr ClpP1 or ClpP2 (Suppl. Fig. S1 ). Given the relatively low levels of ClpP2 155 compared to the major outer membrane protein (MOMP; Fig. 1D ), we cannot conclude that ClpP2 is 156 not present at earlier times or that an antibody specific to chlamydial ClpP2 would be more sensitive 157 to detect such lower levels. We are currently working towards developing antibodies against the 158 chlamydial Clp components. Overall, the expression data indicate that the Clp components are 159 expressed in the RB phase of growth and division. This does not, however, preclude these proteins 160 from having functions at other times during the developmental cycle. 161 162 Bioinformatics analyses identify key residues important for structure and function of each 163 chlamydial ClpP paralog. We hypothesized that each ClpP paralog of C. trachomatis serves 164 distinct functions in the biology and pathogenesis of this unique bacterium, despite their similarity in 165 expression patterns. To further test this hypothesis, we performed a series of bioinformatics analyses. 166
We began by looking at pairwise alignments of the chlamydial ClpP proteins against each other and 167 against ClpP homologs from other bacteria ( Fig. 2A ). Interestingly, each chlamydial ClpP shared 168 more homology to ClpP of E. coli, at 44% and 55% identity with Expect values of 4x10 -51 and 2x10 -169 83 , respectively, and to other ClpP homologs than to its paralog. This observation was supported by 170 the ability of the anti-Pa_ClpP1 antibody to recognize Ctr ClpP2 (Fig. 1C ). The sequence identity 171 between Ctr ClpP1 and Ctr ClpP2 is 39% with an Expect value of 10 -44 . Similarly, the two ClpP 172 paralogs of P. aeruginosa also share a low amount of similarity to each other compared to other 173 ClpP homologs via protein alignment (data not shown), and each serves a distinct function in P. 174 aeruginosa (26). Therefore, these observations support the likelihood that the chlamydial ClpP 175 paralogs have distinct roles. 176 9 A closer analysis of the chlamydial ClpP paralogs provides further evidence for unique 177 functionality of each protein. A 3-dimensional predicted structure alignment of Ctr ClpP1 and ClpP2 178 to E. coli ClpP indicates that the structural architecture would allow for homo-oligomer formation 179 and interaction with chaperones ( Fig. 2B ), though distinct differences in the oligomer interface may 180 prevent hetero-oligomerization (34). Additionally, the catalytic triad active site aligns well for all 181 ClpP homologs analyzed ( Fig. 2B&C ), with variation in structure being mostly limited to the N-and 182 C-termini. Also unique to chlamydial ClpP1 are distinct differences at residues that align to amino 183 acids critical to activation in other bacteria. An alanine at position 37 of Ctr ClpP1 may result in a 184 conformational difference in the P1 pre-activation complex that precludes P1/P2 interaction (35) . 185
This may serve a regulatory role. Further supporting differential regulation is the lack of an aromatic 186 amino acid at position 57 of ClpP1 that is relatively well-conserved in other ClpP homologs, 187 suggesting that Ctr ClpP1 enters the "open" conformation differently than Ctr ClpP2. Ongoing 188 studies are investigating these residues in addition to others that are involved in complex activation. 189
Given the conserved catalytic residues and the structural similarity of the Ctr ClpP proteins to 190 homologs from a diverse set of bacteria, we conclude that the chlamydial ClpP proteins are bona fide 191 protease subunits. However, the predicted structural differences at the termini of the protein and in 192
other key residues suggests that the chlamydial ClpP proteins (i) do not interact with each other, (ii) 193 have specialized functions, and (iii) are regulated differently. 194
195
Overexpression of inactive ClpP1, but not ClpP2, negatively affects Chlamydia. Leveraging 196 recent advances in chlamydial genetics, we next determined the effect of over-expression of ClpP 197 proteins in Chlamydia. We designed and constructed plasmids encoding wild-type or inactive 198 mutants of each clpP paralog, fused to a 6xHis tag, under the control of an anhydrotetracycline 199 (aTc)-inducible promoter (36). Interestingly, we were unable to successfully transform C. 200 trachomatis serovar L2 with plasmids encoding the wild-type clpP genes. The reasons for this are 201 unclear (aside from the inherent difficulty in transforming this obligate intracellular bacterium) but 202 may indicate that leaky expression from the promoter was deleterious to the organism (37). 203 However, we successfully transformed C. trachomatis with plasmids encoding either ClpP1 S92A or 204 ClpP2 S98A active site serine mutants that are known to abolish protease activity (See Fig. 2B ; 205 (38)). To assess the effect of over-expression of these inactive mutants, HEp2 cells were infected 206 with each transformant and expression was induced at 10 hours post-infection with 1 or 10 nM aTc. 207
Both 6-and 14-hour pulses were utilized to determine inclusion morphology at 16 and 24 hours post-208 infection, respectively. At each time point and at the lower concentration of aTc inducer, the 209 localization of the ClpP proteins was within the bacterial cytosol. No noticeable effects were 210 detected after 6h of induction for the ClpP2 mutant, while the ClpP1 mutant induction appeared to 211 have a slight negative impact on the organisms. However, after 14h of over-expression of the mutant 212 ClpP1, noticeably smaller inclusion sizes were observed ( Fig. 3A) whereas over-expression of the 213 mutant ClpP2 had no demonstrable effect ( Fig. 3B ). These data indicate that over-expression of 214 ClpP1 S92A is detrimental to chlamydiae. In support of this conclusion, we were unable to isolate a 215 clonal population of purified ClpP1 S92A transformants as we routinely observed bacterial 216 populations susceptible to antibiotic selection even after multiple passages. This observation 217 indicates that leaky expression may drive plasmid loss as has been observed in other chlamydial 218 transformation systems (37, 39) . 219
220
The ClpP paralogs demonstrate homotypic, but not heterotypic, interactions. To better 221 understand the function of each ClpP paralog and why over-expression of ClpP1 S92A, but not 222 ClpP2 S98A, was detrimental to Chlamydia, we initiated a series of in vivo and in vitro biochemical 223 assays to characterize the properties of the ClpP proteins. Extensive evidence exists from other 224 11 bacterial systems to indicate that ClpP forms a tetradecameric complex composed of two heptameric 225 rings (21-25, 40, 41) . To determine whether the chlamydial ClpP paralogs formed homo-and/or 226 heterooligomers, we first employed the bacterial adenylate cyclase-based two-hybrid (BACTH) 227 system to detect protein-protein interactions. This in vivo assay is based on the reconstitution of 228 adenylate cyclase activity when two functional fragments of Cya from B. pertussis are brought into 229 close proximity by interacting proteins (42). Interactions can be qualitatively determined on Xgal 230 plates and quantified by beta-galactosidase activity. Using the BACTH system, we observed homo-231 oligomerization of each ClpP paralog, but failed to detect interactions between ClpP1 and ClpP2 232 ( Fig. 4A&B ). Importantly, the active site mutants also interacted with each other, indicating that this 233 mutation did not interfere with homo-oligomerization. These data are consistent with the predicted 234 structural and sequence differences noted ( Fig. 2B&C) . 235 As the BACTH system cannot indicate oligomerization state, we next purified recombinant 236 chlamydial ClpP1 and ClpP2 (22 and 23 kDa, respectively), including the active site mutants, and 237 analyzed their migration by native PAGE. As a positive control, we also purified E. coli ClpP (24 238 kDa). Each of the recombinant chlamydial proteins clearly formed a heptamer with a fainter, slower 239 migrating band indicating potential tetradecamer forms (Fig. 4C) . The E. coli ClpP, in contrast, 240 migrated primarily as a tetradecamer with a less intense band at the predicted size of a heptamer. In 241 purifying Ctr ClpP1, we noticed the presence of a doublet band (Suppl. Fig. S2 ). However, the N-242 terminus encodes two additional methionine residues at positions 6 and 7, thus the smaller product 243 may have resulted from an alternative start site when expressed in E. coli. Mass spectrometry 244 analysis of the N-terminus of each band supported this conclusion (Suppl. Fig. S2 ). To ensure that 245 only the larger, full-length product was produced, we mutated the methionine residues to leucine and 246 isoleucine. This recombinant ClpP1 (M6L/M7I) also migrated predominantly as a heptamer in the 247 12 Native PAGE assay ( Fig. 4C ). Therefore, we conclude that the smaller product did not alter the 248 oligomerization state of the protein. 249
Both our bioinformatics predictions and the BACTH data indicated that ClpP1 and ClpP2 do 250 not interact. To further test this, we mixed each recombinant protein in equimolar amounts and 251 analyzed their oligomerization state by Native PAGE. In support of our early observations, we did 252 not observe heteromers of each ClpP paralog as each protein ran as distinct heptamers with no 253 intermediate bands indicative of mixing of the monomers (Fig. 4D ). However, we can neither 254 exclude that the in vitro conditions preclude an interaction between these components nor that these 255 paralogs interact in vivo. Nevertheless, given the differences in predicted structures at the termini of 256 each ClpP paralog ( we could probe the basal protease activity of the ClpP paralogs. While ClpP2 degraded the substrate 264 under our given assay conditions, ClpP1 activity could not be detected (Fig. 5A ). This result for 265 ClpP1 was not due to the presence of the alternative start site product since the M6L/M7I mutant 266 displayed no activity in this assay. We also observed enhanced protease activity for ClpP2 in a 267 sodium citrate buffer, as noted by others (44), but this buffer did not stimulate ClpP1 activity. That 268 ClpP1 lacks the ability to degrade Suc-LY-AMC suggests the N-terminal region of the complex (Fig.  269 2) may block entry of even this small reporter substrate into the active site. Importantly, the activity 270 of the ClpP2 protease was abolished by the active site serine mutation S98A (Fig. 5B ). As a positive 271
13 control, we also tested the activity of the E. coli ClpP complex in our assay conditions and observed 272 degradation of the Suc-LY-AMP compound that was increased by sodium citrate (Fig. 5C ). Thus, in 273 spite of the activity of chlamydial ClpP2, it displayed a significantly lower proteolytic capacity in 274 vitro compared to the E. coli ClpP. The apparent preference of heptameric formation by both 275 chlamydial ClpP1 and ClpP2 could explain the reduced activity as compared to the E. coli ClpP, 276 which preferentially formed tetradecamers in vitro (see Fig. 4C ). These observed differences suggest 277 either that the assay conditions, which work for other bacterial ClpP homologs, are not optimal for 278 chlamydial ClpP proteases or that Chlamydiae tightly regulate the activity of their ClpP complexes. 279 280 ClpP-activating antibiotics stimulate protease activity of ClpP2, but not ClpP1, and block 281 chlamydial growth. Recently, a novel class of antibiotics that target ClpP have been developed (45). 282 ACP and ADEP derivatives activate ClpP by eliminating or reducing its need for chaperone binding. 283
The unregulated proteolysis that results has been demonstrated to eliminate persister bacteria (46). 284
We used these compounds to determine whether the activated chlamydial ClpP proteases could 285 degrade a more complex substrate, casein. As noted with the Suc-LY-AMP substrate, ClpP1 failed to 286 degrade casein in the presence of any of the ACP1 derivatives ( Fig. 6A ). By contrast, the ACP1 287 compounds stimulated ClpP2 to degrade casein ( Fig. 6B ), albeit with some detectable substrate 288 remaining at the end of the assay. As before, the E. coli ClpP was more efficient in degrading the 289 substrate with little to no casein detectable at the end of the assay ( Fig. 6C; (47) ). ClpP2 was thus 290 able, in the presence of these drugs that relax the N-termini of the complex, to degrade larger 291 substrates with intrinsically disordered regions (i.e. casein). The inability to detect proteolytic 292 activity of ClpP1 again suggests that additional factors may regulate its activity consistent with the 293 differences we observed in our bioinformatics analysis (Fig. 2) . Also consistent with the difference 294 in activation is the lack of an aromatic amino acid at residue 57 of ClpP1. This particular residue of 295 14 the hydrophobic pocket has recently been shown to be instrumental in ADEP-induced dysregulation 296 of proteolytic activity, which supports a model where chlamydial ClpP1 is unaffected by activating 297 drugs (35). However, we cannot exclude that we have not identified the optimal conditions necessary 298 to demonstrate the enzyme activity of wild-type ClpP1. 299
As we were able to demonstrate the ability of the ACP1 compounds to activate ClpP2, we 300 next sought to test the effect of these compounds directly on Chlamydia growth and viability. To 301 ensure that any effect on the bacteria was not due to host cell death, we first tested cell viability of 302 infected, ACP-treated HEp2 cells. Indeed, we noted limited loss (~10%) in host cell viability for 303 both 25 and 50 g/mL concentrations following 16 hours of drug treatment (Fig. 6D ), which 304 reinforces that any loss of bacterial viability would not be due to a reduction in host cell viability. 305
The ACP drugs all showed a remarkable impact on Chlamydia at both concentrations tested ( Fig.  306   6E ). The lower drug concentration resulted in a 50-fold reduction in recoverable EBs when added at 307 8 hours post-infection whereas the higher concentration led to almost complete abrogation of 308 chlamydial viability. Given the effects of the ACP compounds on ClpP protease activity in vitro, 309 these data suggest that uncoupling of ClpP2 activity from its cognate ATPase strongly inhibits 310 chlamydial growth. 311 312 Discussion 313 The Clp protease system has been extensively characterized in E. coli and Bacillus subtilis, 314 and its importance in the growth and virulence of various pathogens (opportunistic or not) has been 315 examined (see (23) for review). Since the discovery of the ClpP protease (48), interaction studies 316 demonstrated that the ClpP proteins typically interact as a tetradecameric stack of two heptamers 317 (49). The serine active sites are buried within these barrel-like structures (50). ClpP hydrolysis of 318 large protein substrates is increasingly stimulated in the presence of AAA+ chaperone binding (51). 319 However, complexed ClpP alone processes small substrates of up to 30 amino acids regardless of the 320 presence of ATP, suggesting that active site availability and complex accessibility are the two main 321 mechanisms regulating ClpP activity (52). Substrates that enter this complex by either chaperone-322 mediated or chaperone-independent means are hydrolyzed into short peptides of 6-8 amino acids 323 with some degree of amino acid specificity (44, 53) . 324
While not unprecedented, the presence of two encoded clpP paralogs in a bacterial 325 chromosome is unusual. In P. aeruginosa, another bacterium encoding dual ClpP proteases, the two 326 isoforms have not been shown to interact in any test condition, and the different transcriptional 327 profiles and differential effects on virulence factor production indicate these paralogs likely have 328 distinct roles in P. aeruginosa (26). Conversely, the two ClpP proteins of M. tuberculosis and L. 329 monocytogenes heterologously interact as two homotypic heptamers, which facilitates an increase in 330 function (27, 29, 54) . The activation of one homotypic ClpP heptamer activates the heptamer of the 331 other isoform in M. tuberculosis, providing a novel mechanism for activation (41). Of note is that L. 332 monocytogenes ClpP2 may also form a completely homotypic tetradecamer of one ClpP paralog 333 (55). Again, the Clp proteolytic subunits play an integral role in virulence factor regulation in 334 addition to enhancement of bacterial survival during intracellular growth (56). Taken together, these 335 studies demonstrate the diverse function of dual ClpP peptidase systems in the pathogenesis and 336 growth of various bacteria. 337
The work presented here to characterize the C. trachomatis ClpP paralogs is the first to 338 explore the function and role of the Clp protease system in chlamydiae. Our results suggest that the 339 two ClpP proteases likely serve distinct roles in chlamydial physiology and, we hypothesize, in the 340 complex developmental cycle of this organism. We utilized bioinformatics techniques as an initial 341 approach to investigate the potential function of the ClpP proteins. We observed significant 342 similarity of the chlamydial ClpP paralogs to ClpP homologs of more studied organisms such as E. 343 coli. In support of this, most of the hallmark conserved residues, including the active site triad, are 344 present in the chlamydial ClpP paralogs. Both ClpP1 and ClpP2 have hydrophobic residues aligned 345 with those of other bacterial ClpPs, suggesting the presence of AAA+ adaptor protein docking sites 346 (57). Indeed, chlamydial ClpC and ClpX encode the evolutionarily retained IGF/L loop motifs that 347 facilitate interaction with the ClpP tetradecameric complex (Wood and Ouellette, unpublished 348 observation) (41). In spite of the similarities between the ClpP paralogs, there are also notable 349
differences. The C-termini of both chlamydial ClpPs contain two residues that comprise the 350 hydrophobic pocket (47, 58), but the alignment shows the presence of charged residues (D15, K40, 351 K41, and D66) in ClpP1 while the conserved residues appear to be uncharged. In addition, ClpP1 352 lacks a highly conserved tyrosine residue (D15), a conserved glutamine (A36), and a conserved 353 aromatic residue (V57), all of which contribute to canonical activation and tetradecamer chamber 354 access for other homologs (35). Of note is the predicted alpha helix at the N-terminus of ClpP1 and 355 the C-terminus of ClpP2, which may contribute to some form of steric hindrance to prevent 356 interaction between ClpP1 and ClpP2 (59). Indeed, we could not detect an interaction between ClpP1 357 and ClpP2 using both in vivo and in vitro techniques. Rather, we detected only homoheptameric 358 oligomers. While our in vitro assays have failed to show P1/P2 complex formation, we cannot rule 359 out the possibility of protein modification in vivo promoting heteromers. Further studies examining 360 the role of the N-and C-termini will be conducted to determine whether or not they play a role in 361 complex formation and/or specificity. 362
Given the role of the N-terminal regions in regulation of the ClpP protease via reduced access 363 into the proteolytic complex (60), the hypothesis of a difference in interaction or regulation of the 364
ClpP complexes in C. trachomatis is reasonable based on the data presented here. We detected 365
ClpP2 protease activity against both a small oligopeptide substrate and the more complex casein 366 substrate. However, we did not detect proteolytic activity of ClpP1 in vitro, even in the presence of 367 17 well-characterized drugs that activate ClpP complexes in the absence of an ATPase, which is in 368 agreement with an important and highly regulated role for ClpP1 in C. trachomatis. The structural 369 conservation and presence of the catalytic active site makes it unlikely that ClpP1 is a catalytically 370 inactive protease. Rather, some form of modification or conformational change in structure, possibly 371 chaperone or adaptor mediated, may be necessary to promote full complex formation and activity 372 both in vitro and in vivo. In this model, an unknown regulatory factor may modulate ClpP1 activity. 373
In a manner consistent with our bioinformatics data, ClpP1 may be activated non-canonically, as the 374 mechanism needed to open the channel at the V57 residue is likely different than those targeting the 375 aromatic amino acids present in other homologs. We are investigating this and other possibilities. 376
Our data lead us to hypothesize that each ClpP protein in Chlamydia forms a separate 377 protease complex and, therefore, serves a different function. Whether each ClpP interacts 378 specifically with ClpX or ClpC remains to be determined. However, the genomic proximity of ClpP2 379
to ClpX suggests a likely interaction with ClpX by sequestration immediately following translation; 380 thus, we speculate that ClpP1 likely interacts preferentially with ClpC. Our qPCR data suggest that 381 the clpX-encoding gene follows the clpP2-encoding gene in an operon, further supporting coupled 382 function and an in vivo complex of ClpP2 and ClpX oligomers. Complex formation is currently 383 under investigation as is what role each complex has in vivo. It is also possible that ClpP 384 tetradecamers may function independently in vivo in a housekeeping role to degrade small 385 oligopeptides resulting from degradation of larger proteins and/or import from the host cell. 386
Chlamydiae encode a large repertoire of oligopeptide transporters, and the short peptide substrates 387 are an important source of nutrients, particularly early during infection (61). 388
One of the unexpected outcomes of these initial studies was the failure to transform C. 389 trachomatis with wild-type ClpP constructs. Tet-inducible systems have reduced leakiness compared 390 to other inducible expression systems (62) (63), and this leakiness has been observed in constructs 391 used to transform C. trachomatis (37). When used for the expression of essential gene products or in 392 situations where gene dosage effects are important, the leaky expression can lead to plasmid loss 393 and/or the inability to transform Chlamydia. Based on repeated failure to transform C. trachomatis 394 with vectors encoding the wild-type ClpP proteins, we conclude that leaky expression led to 395 rejection of the plasmid (see also (37)). This suggests that stoichiometric ratios of functional Clp 396 enzymes are important to bacterial homeostasis. In spite of the failure to transform C. trachomatis 397 with wild-type ClpP expressing vectors, we were successful in transforming C. trachomatis with 398 vectors encoding catalytically inactive ClpP mutants. Interestingly, over-expression of the inactive 399
ClpP mutants in Chlamydia resulted in differential effects on chlamydial growth and morphology. 400 ClpP2 S98A has, even upon the highest level of induction, little negative effect on inclusion 401 morphology. The disconnect between the transformation of wild-type and inactive mutants could 402 mean that the ratio of wild-type ClpP2 to its cognate AAA+ chaperone is vital, perhaps to prevent 403 unregulated proteolysis, but incorporation of inactive forms of ClpP2 (activity loss confirmed in 404 vitro, see Fig. 5B ) into the tetradecameric oligomer is not necessarily harmful to C. trachomatis. The 405 ability of ClpP2 to degrade a small peptide reporter (Fig. 5A) is in congruence with a model where a 406 chaperone-independent ClpP2 tetradecamer targets and degrades imported peptides. Given that 407 overexpression of inactive ClpP2 seems to have limited negative impact on chlamydial development, 408 an inactive ClpP2 oligomer may bind small peptides, preventing extensive targeting of other, more 409 vital substrates and negating any dominant negative effect. Conversely, over-expression of ClpP1 410 S92A and its incorporation into the endogenous ClpP1 proteolytic machinery has a clear negative 411 impact on Chlamydia. We observed that the mutant ClpP proteins interacted with the wild-type 412 proteins in the BACTH assay (Wood and Ouellette, data not shown), suggesting the potential of the 413 inactive proteins to form complexes with the endogenous proteins. Overall, these data suggest that, 414 should each mutant protein oligomerize with endogenous wild-type protein in vivo, subunit 415 19 poisoning of the ClpP1 complex is deleterious to chlamydiae whereas the ClpP2 complex is more 416 tolerant. 417
We hypothesize that proteolytic Clp subunit regulation by a chaperone protein is vital to 418 chlamydial survival. Based on our studies with the ACP1 antibiotics, our assays showed that ClpP2 419 acts in a manner similar to other well-characterized ClpP proteases when artificially activated by 420 these compounds (Fig. 6A&C) . Consequently, treatment of Chlamydia-infected cells with ACP1 (or 421 one of its derivatives) significantly and drastically reduced chlamydial growth (Fig. 6E) , which we 422 speculate is due to the effects on ClpP2 function. Whether the negative effect stems from 423 dysregulation of ClpP2 leading to uncontrolled proteolysis, which is supported by the in vitro 424 degradation of casein, or from blocking of ClpP2/AAA+ chaperone complex formation, resulting in 425 the inability to degrade larger substrates not accessible to ClpP2 alone, is currently under 426 investigation. In spite of the inability of ClpP2 S98A over-expression to significantly impact 427 chlamydial growth, the antibiotics data suggest that disruption of ClpP2 via dysregulation of activity 428 is overwhelmingly negative to chlamydial physiology. However, we cannot exclude a possible effect 429 of these antibiotics on ClpP1 in vivo. Clearly, over-expression of ClpP1 S92A was deleterious to 430 chlamydial growth, thus we conclude that each ClpP paralog is essential to normal growth and 431 development. 432
We have shown here an initial characterization of the chlamydial Clp protease system 433 focusing on the ClpP protease components. Overall, the sensitivity of the organisms to perturbations 434 in ClpP activity suggests a critical function for these paralogs in maintenance of chlamydial 435 physiology. We speculate that these systems will also play an integral role in differentiation and 436 possibly persistence (64) (65), which may provide a mechanism that could be leveraged to block 437 growth or eliminate persister cells (46) HEp2 cells seeded in 6-well plates were infected at a multiplicity of infection of 1 with C. 456 trachomatis serovar L2. At the indicated times post-infection, total RNA and DNA were collected 457 from duplicate wells (65). Briefly, total RNA was collected from infected cells using Trizol reagent, 458 extracted with chloroform, and the aqueous phase precipitated with an equal volume of isopropanol 459 according to the manufacturer's instructions (ThermoFisher). DNA was removed from total RNA by 460 rigorous DNase-free treatment (ThermoFisher) before 1 µg was reverse transcribed with Superscript 461 III RT (ThermoFisher). Equal volumes of cDNA were used for qPCR. Total DNA was collected 462 from infected cells by trypsinizing the cells, pelleting for 5 min at 400 xg, and resuspending in PBS. 463 21 Samples were freeze-thawed three times before processing with the DNeasy Blood and Tissue kit 464 according to the manufacturer's instructions (Qiagen). 150 ng of total DNA were used for qPCR. 465
Transcripts and genomic DNA were quantified by qPCR in 25 µL reactions using 2x SYBR Green 466
Master Mix in an ABI7300 thermal cycler in comparison to a standard curve generated from purified 467 C. trachomatis L2 genomic DNA. Transcripts were normalized to genomic DNA. 468 469 C. trachomatis propagation and detection of ClpP2: DFCT28, a GFP-expressing C. trachomatis 470 434/Bu clone (67), was routinely grown in and titered (using the IFU assay) on HeLa cells (68). 471
Briefly, cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 472 10% fetal bovine serum (FBS) and grown at 37 °C with 5% CO 2 . For chlamydial infection 473 experiments, HeLa cells were grown until confluent in 6-well tissue culture dishes and then infected 474 with DFCT28 at an MOI of ~3 using centrifugation at 545 xg for one hour. The infected cells were 475 then incubated at 37 °C with 5% CO 2 with DMEM/FBS supplemented with 0.2 µg/mL 476 cycloheximide and 1x non-essential amino acids. At various times post infection, the medium was 477 removed, cells were washed twice with 2 ml of PBS, and cells were lysed via addition of 200 µL 478
Laemmli buffer with β-mercaptoethanol followed by heating at 90-100 °C for 5 minutes. Chlamydial 479 protein samples or purified, recombinant ClpP samples were run on 12% SDS-PAGE gels and either 480 stained for total protein with Coomassie Brilliant Blue or transferred to nitrocellulose for western 481 blotting. Blots were probed with a rabbit polyclonal anti-Pa_ClpP1 (Pseudomonas aeruginosa 482 designation, similar to ClpP2 from C. trachomatis) diluted 1:10000 in 5% milk Tris-buffered saline 483 (mTBS) or anti-Pa_Clp2 (Pseudomonas aeruginosa designation, similar to ClpP1 from C. 484 trachomatis) at 1:2500. The antibodies were kindly provided by Dr. T. Baker (Massachusetts 485 Institute of Technology) (26). After incubating with primary antibodies, blots were washed with 486 Tween (0.5%)-TBS (TTBS) and then probed with a goat, anti-rabbit IgG poly-HRP conjugated 487 22 secondary antibody (Thermo Scientific 32260) diluted 1:1000 in mTBS. As a control for chlamydial 488 protein, blots were also probed for the major outer membrane protein (MOMP) using a mouse 489 monoclonal anti-MOMP antibody (1:1000; Abcam, ab41193) and a goat anti-mouse IgG HRP 490 conjugated secondary antibody (1:2000; Millipore AP124P). After incubation with the secondary 491 antibodies, blots were washed with TTBS followed by TBS and then incubated with 492 chemiluminescent substrate (EMD Millipore Immobilon ECL) for imaging on a Bio-Rad Chemidoc 493 Plasmid Construction: A full list of the primers and plasmids used is included in the supplementary 508 material (S1). Plasmids for the Bacterial Adenylate Cyclase Two-Hybrid (BACTH) system were 509 cloned using the Gateway® recombination system (74). The genes were amplified from Chlamydia 510 trachomatis L2 genomic DNA with primers designed to add an attB recombination site on either side 511 23 of the gene. The PCR products were then incubated with a pDONR TM 221 entry vector (containing 512 attP recombination sites) in the presence of BP Clonase II (Invitrogen) that inserts the gene via the 513 flanking attB sites and removes ccdB endotoxin flanked by the attP sites encoded on the plasmid, 514 allowing for positive selection. The result of the BP reaction was an entry vector containing the gene 515 of interest flanked by attL sites. 2 μL were transformed into DH5α chemically competent E. coli and 516 plated onto an LB agar plate containing 50 μg/mL kanamycin. Plasmid from an individual colony 517 was purified and used for the LR reaction into one of three destination vectors (pST25-DEST, 518 pSNT25-DEST, or pUT18C-DEST). The same entry vector for any given gene was used for all three 519 LR reactions to insert into the destination vector with LR Clonase II. 150 ng of the entry vector was 520 incubated with 150ng of destination vector for 1 hour at room temperature. 2 μL were used to 521 transform XL1 E. coli, which were plated on the appropriate selection plate. Purified plasmid from 522 an individual colony was sequence verified prior to use the in BACTH assay (see below). 523
Constructs for chlamydial transformation were created using the HiFi Cloning (New England 524 Biolabs) protocol. To add the C-terminal 6xHis tag to the Clp proteins, the genes were amplified 525 from the genome with a primer to add the poly-histidine tag. These products served as the template 526 for PCR reactions to add the necessary overlap for the HiFi reaction. Primers were generated using 527 the NEBuilder ® assembly tool available from New England BioLabs (http://nebuilder.neb.com). The 528 backbone used was the pTLR2 derivative of the pASK plasmid (36). The pTLR2 backbone was 529 digested using FastDigest BshTI and Eco52I restriction enzymes and dephosphorylated using 530 FastAP (ThermoFisher), and then 50ng of digested plasmid was incubated with a 2:1 ratio of insert 531 copy number to backbone and 2x HiFi master mix (NEB). Following a 15 minute incubation of the 532 reaction mix at 50° C, 2 μL of the reaction was transformed into DH5α chemically competent E. coli 533 (NEB) and plated on the appropriate antibiotic selection plate. Positive clone sequences were 534 verified by Eurofins Genomics. Sequence verified plasmids were transformed into dam-/dcm-E. coli 535 24 (New England BioLabs) in order to produce demethylated plasmid, which was sequence and digest 536 verified prior to transformation into C. trachomatis (see below). 537
Strains created or used in this study are listed in the supplementary material. E. coli strains 538 were maintained on LB agar plates and grown in LB medium or on LB agar plates supplemented 539 with 100 µg/ml ampicillin as needed. Chlamydial genomic DNA for cloning was obtained from EBs 540 using a phenol:chloroform extraction after extensive heat treatment in the presence of proteinase K 541 (75), and E. coli genomic DNA was isolated using sodium hydroxide lysis of colonies. The 542 chlamydial clpP1 and clpP2 along with clpP from E. coli were amplified via PCR using the primers 543 listed in Supplemental Information and Phusion DNA polymerase (Thermo Scientific). PCR 544 products were cloned into the pLATE31 expression vector from Thermo Scientific as directed by the 545 manufacturer to create fusion proteins with a C-terminal 6x His-tag. Plasmids were initially 546 transformed into E. coli NEB10 and selected on LB agar ampicillin plates. Transformants were 547 screened for inserts using colony PCR with Fermentas Master Mix (Thermo Scientific) and positive 548 clones were grown for plasmid isolation (GeneJet Plasmid Miniprep Kit, Thermo Scientific). DNA 549 inserts were sequenced by Macrogen USA and sequence-verified plasmids were then transformed 550 into E. coli BL21(DE3) bacteria for protein production. 551 552 Chlamydial Transformation: The protocol followed was a modification of the method developed by 553 Mueller and Fields (76) . For transformation, 10 6 C. trachomatis serovar L2 EBs (25667R) naturally 554 lacking the endogenous plasmid were incubated with 2 μg of unmethylated plasmid in a volume of 555 50 μL CaCl 2 at room temperature for 30 minutes. Each reaction was sufficient for a confluent 556 monolayer of McCoy cells in one well of a six well plate that had been plated a day prior. The 557 transformants were added to a 1 mL overlay of room temperature HBSS per well, and an additional 1 558 mL of HBSS was then added to each well. The plate was centrifuged at 400 xg for 15 min at room 559 25 temperature, where the beginning of this step was recorded as the time of infection. Following the 560 spin, the plate was incubated for 15 minutes at 37° C. This infection was recorded as T 0 . The 561 inoculum was aspirated at the end of the incubation and replaced with antibiotic-free DMEM+10% 562 FBS. 8 hours post-infection, the media was replaced with DMEM containing 1 μg/mL 563 cycloheximide, 10 μg/mL gentamicin, and 1 U/mL penicillin. Cells infected with transformants were 564 passaged every 48 hours until a population of penicillin resistant bacteria was established. These EBs 565
were then harvested and frozen in sucrose/phosphate (2SP; (66)) solution at -80° C prior to titration. 566 567
Determining the Effect of Overexpression of Clp Mutant Proteins via Immunofluorescence 568
Analysis: Transformed C. trachomatis containing a mutant clp gene under control of an 569 anhydrotetracycline (aTc) inducible promoter was used to infect a monolayer of HEp2 cells on 570 coverslips with penicillin as a selection agent. Samples were induced with increasing, subtoxic 571 amounts of aTc at 8 hours post-infection and were methanol fixed after either a 6 hour or 14 hour 572 pulse (16 or 24 hours post-infection). Fixed cells were incubated with an anti-Ctr serovar L2 guinea 573 pig primary antibody (kindly provided by Dr. Rucks, UNMC) to stain for the organism and a goat 574 anti-guinea pig Alexa488 conjugated secondary antibody for visualization of organisms within the 575 inclusion. Additionally, a mouse anti-6xHis tag was used, followed by a goat anti-mouse Alexa594 576 secondary antibody for confirmation of protein expression and localization. Finally, the samples 577 were stained with DAPI to visualize the host cell and bacterial DNA. Representative images were 578 taken on a Zeiss Fluoview1000 laser scanning confocal microscope with a 60x objective and 2x 579 digital zoom and were equally color corrected using Adobe Photoshop CC. 580 581
Determining Protein-Protein Interactions with the BACTH System:
To test interaction of the Clp 582 proteins, the Bacterial Adenylate Cyclase Two-Hybrid (BACTH) assay was utilized. This assay 583 26 relies on reconstitution of adenylate cyclase activity in adenylate cyclase deficient (Δcya) DHT1 E. 584 coli. The genes of interest are translationally fused to one of either subunit, denoted as T18 and T25, 585 of the B. pertussis adenylate cyclase toxin. Each clpP gene cloned into one of the pST25, pSNT25, 586 or pUT18C Gateway ® vectors was tested for both homotypic and heterotypic interactions (10) . One 587 plasmid from the T25 background and one from the T18 background were co-transformed into the 588 DHT1 CaCl 2 competent E. coli and were plated on a double antibiotic minimal M63 medium 589 selection plate supplemented with 0.5 mM IPTG for induction of the protein, 40 μg/mL Xgal to give 590 a visual readout upon cleavage, and 0.2% maltose as a unique carbon source. These plates also 591 contain 0.04% casein hydrolysate to supplement the bacteria with the branched chain amino acids as 592
Δcya DHT1 E. coli cannot synthesize these amino acids. Blue colonies were indicative of positive 593 interaction between proteins since both the lac and mal operons require reconstituted cAMP 594 production from interacting T25 and T18 fragments to be expressed. Leucine zipper motifs were 595 used for controls in pKT25 and pUT18C backgrounds on the appropriate antibiotic selection plates 596 because these have been previously shown to interact (77). β-galactosidase activity was then 597 measured from 8 colonies to quantify protein interactions. Random positive colonies were used to 598 inoculate individual wells and grown 24 hours at 30° in M63 with 0.2% maltose and appropriate 599 antibiotics. These bacteria were permeabilized with 0.1% SDS and chloroform prior to addition of 600 0.1% o-nitrophenol-β-galactoside (ONPG). The reaction was stopped using 1 M NaHCO 3 after 601 precisely 20 minutes of incubation at room temperature. Absorbance at the 405 wavelength was 602 recorded and normalized to bacterial growth (OD 600 ), dilution factor, and time (in minutes) of 603 incubation prior to stopping the reaction. Totals were reported in relative units ( RNA and DNA were collected at the indicated times post infection and processed as described in 895 Materials and Methods. Equivalent amounts of cDNA were used for each assay and analyzed in 896 triplicate. Results were reported as a ratio of cDNA to genomic DNA. Standard deviations for each 897 were typically less than 10% of the sample. Note that some transcripts were not detectable at 1 hpi. 898
Temporal expression of (C) ClpP2, using a Pseudomonas aeruginosa ClpP1-specific antibody, and 899 Escherichia coli (Ec), Bacillus subtilis (Bs), Mycobacterium tuberculosis (Mtb), and Pseudomonas 908 aeruginosa (Pa). Conserved residues highlighted in varying shades of blue depending on 909 conservation strength across species, with the catalytic triad in red, the oligomer interface in yellow, 910 and the hydrophobic docking region in green. Residues in which ClpP1 has a different substitution 911
